Xtx Topco LTD Cytek Biosciences, Inc. Transaction History

Xtx Topco LTD

$1.3 Billion
Q3 2024

A detailed history of Xtx Topco LTD transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 26,150 shares of CTKB stock, worth $155,592. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,150

Holding current value

$155,592

% of portfolio

0.01%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$4.73 - $6.73 $123,689 - $175,989	26,150 New	26,150 $144,000
Q1 2024 May 13, 2024	BUY	$6.29 - $9.15 $124,818 - $181,572	19,844 New	19,844 $133,000

Others Institutions Holding CTKB

# of Institutions

135

Shares Held

72.1M

Call Options Held

400

Put Options Held

Black Rock Inc. New York, NY

17.1M
Shares

$102 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$70.1 Million
0.0% of portfolio
Brown Capital Management LLC Baltimore, MD

9.49M
Shares

$56.5 Million
1.15% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

6.66M
Shares

$39.6 Million
0.85% of portfolio
State Street Corp Boston, MA

4.17M
Shares

$24.8 Million
0.0% of portfolio

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $801M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account